Fu Yu Corporation Limited (SG:F13) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Fu Yu Corporation Limited has reported a notable financial turnaround with a net profit of S$0.1 million in the first half of 2024, a stark contrast to the S$3.9 million loss in the previous year. This achievement was driven by a 78% surge in revenue to S$126.7 million, credited to robust performances in manufacturing and supply chain management, with a significant boost from the new biomedical segment. The company anticipates continued growth due to rising order volumes and project inquiries.
For further insights into SG:F13 stock, check out TipRanks’ Stock Analysis page.
